Operational research in malawi: Making a difference with cotrimoxazole preventive therapy in patients with tuberculosis and HIV

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Harries, Anthony D ^a,b   Zachariah, Rony ^c   Chimzizi, Rhehab ^d   Salaniponi, Felix ^e   Gausi, Francis ^f   Kanyerere, Henry ^f   Schouten, Erik J ^g   Jahn, Andreas ^h,i   Makombe, Simon D ^h   Chimbwandira, Frank M ^h   Mpunga, James ^f  

^a INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Brussels Operational Center   (Luxembourg)

^d Management Sciences for Health   (Ghana)

^e Futures Group Europe   (Kenya)

^f National Tuberculosis Control Programme Malawi   (Malawi)

^g Ministry of Health ^*  (Malawi)

^h MINISTRY OF HEALTH   (Malawi)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Africa; cotrimoxazole preventive therapy; HIV AIDS; Malawi; Operational research; tuberculosis

Indexed keywords

ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; COTRIMOXAZOLE;

ARTICLE; COMORBIDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALAWI; MORTALITY; OUTCOME ASSESSMENT; PRIMARY PREVENTION; TREATMENT OUTCOME; TUBERCULOSIS;

ANTI-INFECTIVE AGENTS; ANTI-RETROVIRAL AGENTS; COMORBIDITY; HIV INFECTIONS; HUMANS; MALAWI; OUTCOME ASSESSMENT (HEALTH CARE); PRIMARY PREVENTION; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; TUBERCULOSIS;

EID: 79960658168     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-593     Document Type: Article

References (37)

1. Operational research in low-income countries: what, why and how? Zachariah R, Harries AD, Ishikawa N, Rieder HL, Bissell K, Laserson K, Massaquoi M, van Herp M, Reid T, Lancet Infect Dis 2009 9 711 717
2. TB Research. Putting Research into Policy and Practice. The experience of the Malawi National Tuberculosis Control Programme. Communicable Diseases Cluster, WHO, Geneva, Switzerland: WHO. WHO/CDS/CPC/TB/99.268 1999
3. Tuberculosis research in Malawi: making it count. Harries AD, Hargreaves NJ, Banda HT, Kang'ombe C, Zachariah R, Spielmann MP, Kwanjana JH, Salaniponi FML, Recent Advances and Research Updates 2001 2 103 118
4. Malawi National HIV/AIDS Estimates 2003. National AIDS Commission, Technical report 2004 Image Printing Works, Lilongwe
5. Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba hospital, Malawi. Harries AD, Nyangulu DS, Kang'ombe C, Ndalama D, Glynn JR, Banda H, Wirima JJ, Salaniponi FM, Liomba G, Maher D, Nunn P, Trans Roy Soc Trop Med & Hyg 1998 92 343 347 (Pubitemid 28286941)
6. Treatment outcome of patients with smear-negative and smear-positive pulmonary tuberculosis in the National Tuberculosis Control Programme, Malawi. Harries AD, Nyirenda TE, Banerjee A, Boeree MJ, Salaniponi FML, Trans Roy Soc Trop Med Hyg 1999 93 443 446 (Pubitemid 29405881)
7. Early chemoprophylaxis with trimethorpim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire: a randomised trial. Anglaret X, Chene G, Attia A, Toure S, Lafont S, Combe P, Manlan K, N'Dri-Yoman T, Salamon R, the Cotrimo-CI study group, Lancet 1999 353 1463 68 (Pubitemid 29204363)
8. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d'Ivoire: a randomised controlled trial. Wiktor SZ, Sassan-Morokro M, Grant AD, Abouya L, Karon JM, Maurice C, Djomand G, Ackah A, Domoua K, Kadio A, Yapi A, Combe P, Tossou O, Roels TH, Lackritz EM, Coulibaly D, De Cock KM, Coulibaly IM, Greenberg AE, Lancet 1999 353 1469 1476
9. Provisional WHO/UNAIDS secretariat recommendations on the use of cotrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa. UNAIDS and WHO, Geneva, Switzerland: UNAIDS and WHO 2000
10. Co-trimoxazole in HIV-1 infection. Boeree MJ, Harries AD, Zijlstra EE, Taylor TE, Molyneux ME, Lancet 1999 354 334
11. Voluntary counselling, HIV testing and adjunctive treatment with cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi. Zachariah R, Spielmann MP, Chinji C, Gomani P, Arendt V, Hargreaves NJ, Salaniponi FM, Harries AD, AIDS 2003 17 1053 1061 (Pubitemid 36549718)
12. Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi. Mwaungulu FBD, Floyd S, Crampin AC, Kasimba S, Malema S, Kanyongoloka H, Harries AD, Glynn JR, Fine PEM, Bull World Health Organ 2004 82 354 363 (Pubitemid 38715072)
13. Efficacy and safety of two dosages of cotrimoxazole as preventive treatment for HIV-infected Malawian adults with new smear-positive tuberculosis. Boeree MJ, Sauvageot D, Banda HT, Harries AD, Zijlstra EE, Trop Med Int Health 2005 10 723 733 (Pubitemid 41098139)
14. Counselling, HIV testing and adjunctive cotrimoxazole for TB patients in Malawi: from research to routine implementation. Chimzizi RB, Harries AD, Manda E, Khonyongwa A, Salaniponi FM, Int J Tuberc Lung Dis 2004 8 938 944 (Pubitemid 39024894)
15. Compliance with cotrimoxazole prophylaxis for the prevention of opportunistic infections in HIV-positive tuberculosis patients in Thyolo district, Malawi. Zachariah R, Harries AD, Arendt V, Wennig R, Schneider S, Spielmann M, Panarotto E, Gomani P, Salaniponi FM, Int J Tuberc Lung Dis 2001 5 843 846 (Pubitemid 32843678)
16. Changes in Escherichia coli resistance to cotrimoxazole in tuberculosis patients and in relation to co-trimoxazole prophylaxis in Thyolo, Malawi. Zachariah R, Harries AD, Spielmann MP, Arendt V, Nchingula D, Mwenda R, Courtielle O, Kirpach P, Mwale B, Salaniponi FML, Trans Roy Soc Trop Med Hyg 2002 96 202 204 (Pubitemid 34846570)
17. Cotrimoxazole prophylaxis in HIV-infected individuals after completing anti-tuberculosis treatment in Thyolo, Malawi. Zachariah R, Spielmann MP, Harries AD, Gomani P, Bakali E, Int J Tuberc Lung Dis 2002 6 1046 1050 (Pubitemid 36054957)
18. Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis. Harries AD, Libamba E, Schouten EJ, Mwansambo A, Salaniponi FM, Mpazanje R, BMJ 2004 329 1163 1166 (Pubitemid 39524779)
19. Scaling up antiretroviral therapy in resource-poor settings. Harries AD, Schouten E, Libamba E, Lancet 2006 367 1870 1872 (Pubitemid 43833194)
20. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R, AIDS 2008 22 1897 1908
21. Lower early mortality rate among patients receiving antiretroviral treatment at clinics offering cotrimoxazole prophylaxis in Malawi. Lowrance D, Makombe S, Harries A, Yu J, Aberle-Grasse J, Eiger O, Shiraishi R, Marston B, Ellerbrock T, Libamba E, J Acquir Immune Defic Syndr 2007 46 56 61 (Pubitemid 47507434)
22. Cost-effectiveness of HIV treatment in resource-poor settings-the case of Cote d'Ivoire. Goldie SJ, Yazdanpanah Y, Losina E, Weinstein MC, Anglaret X, Walensky RP, Hsu HE, Kimmel A, Holmes C, Kaplan JE, Freedberg KA, N Eng J Med 2006 355 1141 1153 (Pubitemid 44394920)
23. Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort. Walker AS, Ford D, Gilks CF, Munderi P, Ssali F, Reid A, Katabira E, Grosskurth H, Mugyenyi P, Hakim J, Darbyshire JH, Gibb DM, Babiker AG, Lancet 2010 375 1278 1286
24. Effect of cotrimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Mermin J, Lule J, Ekwaru JP, Malamba S, Downing R, Ransom R, Kaharuza F, Culver D, Kizito F, Bunnell R, Kigozi A, Nakanjako D, Wafula W, Quick R, Lancet 2004 364 1428 1434 (Pubitemid 39370718)
25. Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members. Mermin J, Lule J, Ekwaru JP, Downing R, Hughes P, Bunnell R, Malamba S, Ransom R, Kaharuza F, Coutinho A, Kigozi A, Quick R, AIDS 2005 19 1035 1042 (Pubitemid 40961143)
26. Effectiveness of cotrimoxazole prophylaxis on mortality in adults with tuberculosis in rural South Africa. Grimwade K, Sturm AW, Nunn AJ, Mbatha D, Zungu D, Gilks CF, AIDS 2005 19 163 168 (Pubitemid 40409534)
27. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Chintu C, Bhat GJ, Walker AS, Mulenga V, Sinyinza F, Lishimpi K, Farrelly L, Kaganson N, Zumla A, Gillespie SH, Nunn AJ, Gibb DM, on behalf of the CHAP trial team, Lancet 2004 364 1865 1871 (Pubitemid 39536090)
28. Joint WHO/UNAIDS/UNICEF statement on use of cotrimoxazole as prophylaxis in HIV exposed and HIV infected children. World Health Organization/UNAIDS/ UNICEF, Geneva, Switzerland: WHO 2004
29. Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease. Thera MA, Sehdev PS, Coulibaly D, Traore K, Garba MN, Cissoko Y, Kone A, Guindo A, Dicko A, Beavogui AH, Djimde AA, Lyke KE, Diallo DA, Doumbo OK, Plowe CV, J Infect Dis 2005 192 1823 1829 (Pubitemid 41587836)
30. Co-trimoxazole preventive therapy for HIV-positive persons in Malawi. Ministry of Health, Malawi, 2005 http://www.hivunitmohmw.org/uploads/Main/CTX- policy-2005.pdf accessed 20th July 2011
31. Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults. Recommendations for a public health approach. World Health Organization, Geneva, Switzerland: WHO 2006
32. th July 2011
33. st December 2010. Ministry of Health, Malawi
34. Translating evidence into policy in low-income countries: lessons from co-trimoxazole preventive therapy. Hutchinson E, Droti B, Gibb D, Chishinga N, Hoskins S, Phiri S, Parkhurst J, Bull World Health Organ 2011 89 312 316
35. The published research paper: is it an important indicator of successful operational research at programme level? Zachariah R, Tayler-Smith K, Ngamvithayapong-Yanai J, Ota M, Murakami K, Ohkado A, Yamada N, Van den Boogaard W, Draguez B, Ishikawa N, Harries AD, Trop Med Int Health 2010 15 1274 1277
36. Defining research to improve health systems. Remme JHF, Adam T, Becerra-Posada F, D'Arcangues C, Devlin M, Gardner C, Ghaffar A, Hombach J, Kengeya JFK, Mbewu A, Mbizvo MT, Mirza Z, Pang T, Ridley RG, Zicker F, Terry RF, PLoS Medicine 2010 7 1001000
37. Evaluation of an international training course to build programmatic capacity for tuberculosis control. Ohkado A, Pevzner E, Sugiyama T, Murakami K, Yamada N, Cavanaugh S, Ishikawa N, Harries AD, Int J Tuberc Lung Dis 2010 14 371 373